Pharmaceuticals, Biotechnology and Life Sciences
Multiple contracts with VA medical centers already executed for Pure-Vu EVS under the sole source supplier designation, with additional centers…
Results showed evidence of clinical activity for cirtuvivint in advanced cancer patientsSAN DIEGO, Sept. 29, 2022 (GLOBE NEWSWIRE) — Biosplice…
MINNEAPOLIS, Sept. 29, 2022 (GLOBE NEWSWIRE) — Panbela Therapeutics, Inc. (Nasdaq: PBLA), a clinical stage company developing disruptive therapeutics for…
VANCOUVER, British Columbia, Sept. 28, 2022 (GLOBE NEWSWIRE) — Sirona Biochem Corp. (TSX-V: SBM) (FSE: ZSB) (US-OTC: SRBCF) (“Sirona”) announces…
Dupixent® (dupilumab) approved by FDA as the first and only treatment indicated for prurigo nodularis Dupixent significantly reduced itch and…
Saint Herblain (France), September 28, 2022 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA) (the “Company”), a specialty vaccine company,…
SOUTH SAN FRANCISCO, Calif., Sept. 28, 2022 (GLOBE NEWSWIRE) — Aligos Therapeutics, Inc. (Nasdaq: ALGS), a clinical stage biopharmaceutical company…
NEW YORK, Sept. 28, 2022 (GLOBE NEWSWIRE) — Cellectis (the “Company”) (Euronext Growth: ALCLS – NASDAQ: CLLS), a clinical-stage biotechnology…
Financial highlights Cash and cash equivalents totaled €209 million as of June 30, 2022Net loss totaled €10 million for the…
Acquisition includes late-stage rare disease portfolio with anticipated 2023 clinical milestones and first potential product approval as early as late…